Microwave Ablation Market Size, Trends, Share, Growth | Report 2022-2030

The global microwave ablation market was estimated at USD 133.41 million in 2021 and it is expected to surpass around USD 289.92 million by 2030, poised to grow at a CAGR of 9.01% from 2022 to 2030.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39729

The microwave ablation market is growing rapidly due to its increasing incidences of tumors of the liver, lung, bone, and kidney globally. Additionally, a growing number of processes with the image-guided device is also expected to fuel the growth of the market. Technical advancements and a rising preference for minimally invasive surgeries is also expected to witness the growth of microwave ablation devices in near future. However, the high cost of devices used during the microwave ablation procedures and the preference for radiofrequency ablation devices over microwave ablation (MWA) devices by the respective surgeons is hindering the market growth.

Microwave ablation (MWA) is a thermal technology, that incorporates MRI and radio-frequency equipment for the treatment of various benign and malignant tumors. Microwave ablation is being explored for an assortment of restorative treatments including treatment of endometrial bleeding, uterine myomas, atrial fibrillation, and cancerous tumors within the liver, kidneys, pancreas, lungs, and breast. MWA offers a less-invasive elective to surgical resection of tumors, allowing shortened recovery times and offering a rational treatment choice for cancer patients who are not candidates for surgery. The microwave ablation procedure uses the most technically advanced devices that provide short ablation time, higher temperature for the ablation, weakened heat-sink effect than that of radiofrequency ablations, and large ablation zones. These factors are proven to improve tumor ablation efficacy using the MWA process.

The microwave ablation market is segmented based on component type into the generator, power distribution system, and accessories. Based on application, the microwave ablation market is segmented into oncology, cardiovascular, urology, orthopedic, and others. Additionally, based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and research laboratories.

The companies are working on developing innovative microwave ablation systems with the help of their research and innovation. For instance, In July 2020, Ethicon (Subsidiary of Johnson & Johnson Medical Devices Company) announced that the U.S. Food and Drug Administration (FDA) has approved their NEUWAVE Microwave Ablation System. Additionally, Medtronic plc has declared the breakthrough device designation status grant for the Emprint ablation catheter kit from the U.S. Food and Drug Administration (FDA), in April 2021. However, the higher number of product recalls may also impede market growth. For instance, the Solero Microwave Tissue Ablation (MTA) System and accessories from Angiodynamics Inc. has been terminated in June 2020 due to a lack of updates from the manufacturers to decrease the potential risks to patients due to delay in performing the procedure.

Scope of The Report

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39729

COVID-19 Impact 

The global microwave ablation market is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies had disrupted the manufacturing and supply of raw materials. However, a microwave ablation system can be used for patients suffering from COVID-19 with hepatic tumors. This device will support in faster treatment with recovery timeless and short.

Drivers and Restraints

Increasing incidences of benign and malignant tumor of lung, liver, bone and kidney throughout the globe is the primary factor driving the growth of the microwave ablation devices market. Moreover, the rising number of tumor ablation procedure with the help of image-guided device will also propel the growth of microwave ablation devices market. Additionally, change in the lifestyle of people and unhealthy eating habit along with consumption of alcohol and tobacco is also fueling the number of cancer cases which will ultimately upsurge the growth of microwave ablation devices market.

Increasing demand for minimally invasive procedures and technological advancement is also responsible for the robust growth of microwave ablation devices market throughout the forecast period. The high-cost device associated with high risk during microwave ablation procedure may also impact the sale of microwave ablation devices over the next decade. Also, the high preference of surgeon towards RF ablation device over the microwave ablation device may deter the growth of this market.

Related Reports

• Endometrial Ablation Market Report 2022-2030 - https://www.visionresearchreports.com/endometrial-ablation-market/38457
• Tumor Ablation Market Report 2022-2030 - https://www.visionresearchreports.com/tumor-ablation-market/37239
• Radiofrequency Ablation Devices Market Report 2022-2030 - https://www.visionresearchreports.com/radiofrequency-ablation-devices-market/37184

Key Players

• Angio Dynamics
• Boston Scientific Corporation
• Emblation microwave
• Huber+Suhner
• Johnson & Johnson Services Inc.
• Med Waves
• Medtronic PLC
• MedWaves Inc.
• Miramar labs
• Neu Wave Medical
• Pearson Medical
• Symple Surgical
• Urologix
• Vison Medical USA Inc.

Market Segmentation

• By Component Type
  •  Generator
  • Power Distribution System
  • Accessories
• By Application
  • Oncology
  • Cardiovascular
  • Urology
  • Orthopedic
  • Others
• By End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Research Laboratories
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & AfricaTop of Form

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39729

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://qyresearchmedical.com/